As the UK Scientific and Site Head, Dr. Ken Macnamara is instrumental in advancing potential therapies through AskBio’s early portfolio program.

Dr. Macnamara has a wealth of R&D, business operations, financial planning, intellectual property, and quality/compliance experience gained from his time at start-up and multinational firms. He joined AskBio in 2019 after serving as Chief Operating Officer at Synpromics, a gene control synthetic promoter technology company acquired by AskBio. Dr. Macnamara began his career at the University of Edinburgh, where he earned a PhD in chemistry before helping to launch Lab901, a leading electrophoresis equipment and consumables company. There, he was a product development manager responsible for developing the TapeStation and ScreenTape technologies from concept to market success. Agilent Technologies acquired Lab901 in 2011. Dr. Macnamara then served as R&D Director for the Microfluidics business at Agilent, setting the R&D strategy and leading the team through tremendous business growth.